Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Psychoneuroendocrinology. 2018 Nov 22;102:95–104. doi: 10.1016/j.psyneuen.2018.11.027

Table 2.

Results of t-tests comparing PTSD and non-PTSD group means for plasma adrenocorticotropin (ACTH) and cerebrospinal fluid neuroactive steroids and ratios.

Cerebrospinal Fluid Neuroactive Steroid Indices (pg/ml) TC
Mean ± SD
(n)
PTSD
Mean ± SD
(n)
ta dfa Pa Cohen’s d [95% CI]a
Progesterone 13.0 ± 12.2 17.1 ± 11.6 0.87 23.7 .39 0.34 [−0.47; 1.16]
 (PROG) (14) (12) 0.61 20.0 .55 0.26 [−0.62; 1.13]
5α-Dihydroprogesterone: 573.7 ± 669.7 309.4 ± 293.7 −1.37 20.1 .19 −0.53 [−1.34; 0.28]
 (5α-DHP) (15) (12) −1.68 21.0 .11 −0.69 [−1.58; 0.19]
Allopregnanolone: 18.2 ± 10.6 15.1 ± 9.7 −0.78 24.5 .44 −0.30 [−1.10; 0.50]
 (Allo) (15) (12) −0.98 21.0 .34 −0.41 [−1.27; 0.46]
Pregnanolone: 5.1 ± 4.1 17.0 ± 23.6 1.72 11.5 .11 0.67 [−0.15; 1.49]
 (Pregnan) (15) (12) 1.71 21.0 .10 0.71 [−0.18; 1.59]
Allo + Pregnan 23.3 ± 10.6 32.1 ± 23.7 1.20 14.5 .25 0.46 [−0.34; 1.27]
(15) (12) 1.00 21.0 .33 0.41 [−0.46; 1.28]
Dehydroepiandrosterone: 839.4 ± 889.0 618.9 ± 479.3 −0.87 25.6 .39 −0.32 [−1.08; 0.44]
 (DHEA) (17) (13) −1.28 24.0 .21 −0.50 [−1.32; 0.32]
DHEA-Sulfate: 2121 ± 1572 2059 ± 2087 −0.09 19.7 .93 −0.03 [−0.82; 0.75]
 (DHEAS) (16) (12) −0.16 22.0 .87 −0.07 [−0.91; 0.78]
Plasma
Adrenocorticotropic Hormone (ACTH) 26.6 ± 17.8 21.5 ± 10.7 −0.92 24.7 .36 −0.36 [−1.17; 0.45]
(16) (11)
Ratios Indicating Possible Enzyme Blocks in the Allo and Pregnan Synthesis Pathways
5α-DHP/PROG 64.1 ± 60.4 25.8 ± 24.2 −2.09 16.3 .05t −0.86 [−1.75; 0.03]
(13) (11) −2.14 18.0 <.05* −0.94 [−1.91; 0.03]
Allo/5α-DHP 0.11 ± 0.21 0.12 ± 0.17 0.18 23.9 0.86 0.07 [−0.74; 0.18]
(14) (12) 0.48 20.0 0.64 0.20 [−0.68; 1.08]
Ratios Integrating Possible Synthesis Blocks Across Neurosteroidogenesis
(Allo + Pregnan)/5α-DHP 0.13 ± 0.25 0.36 ± 0.58 1.30 14.4 .21 0.51 [−0.31; 1.34]
(14) (12) 1.55 20.0 .14 0.65 [−0.25; 1.55]
PROG/ACTH 0.75 ± 0.83 0.93 ± 0.49 0.65 19.9 .52 0.27 [−0.61; 1.15]
(13) (10)
(Allo + Pregnan)/ACTH 1.27 ± 1.11 1.76 ± 1.84 0.75 13.6 .47 0.31 [−0.55; 1.17]
(14) (10)
Ratios Reflecting
 Inhibitory to Excitatory Neurotransmission Balance
(Allo + Pregnan)/DHEA 0.047 ± 0.03 0.116 ± 0.15 1.56 11.9 .14 0.61 [−0.21; 1.42]
(15) (12) 1.85 21.0 .08 0.76 [−0.12; 1.65]
(Allop + Pregnan)/DHEAS 0.016 ± 0.01 0.035 ± 0.05 1.28 12.5 .22 0.50 [−0.31; 1.31]
(15) (12) 1.38 21.0 .18 0.57 [−0.31; 1.44]

Note:

a

The first line of results for each biomarker is for the unadjusted t-test (using Welch’s correction for unequal variances); the second line reports the adjusted statistics controlling for plasma ACTH levels. t = 0.05 ≤ p < 0.10;

*

= p < 0.05.